Skip to content
terlipressin

Structure via PubChem · Public domain (PubChem)

EntityQ324147· pop 18· linked from 75 articles

terlipressin

Sign in to save

Also known as SID124896640, Terlipressine, H-Gly-Gly-Gly-Cys(1)-Tyr-Phe-Gln-Asn-Cys(1)-Pro-Lys-Gly-NH2

Terlipressin, sold under the brand name Terlivaz among others, is an analogue of vasopressin used as a vasoactive drug in the management of low blood pressure. It has been found to be effective when norepinephrine does not help. Terlipressin is a vasopressin receptor agonist.

In the Vinony graph

Vinony's link graph records 75 inbound references to terlipressin, and connects out to arginine vasopressin, lithium and medication.

It is catalogued under topics including Antidiuretics, Antihypotensive agents and ECHA InfoCard ID from Wikidata.

Vinony links it to 18 Wikipedia language editions.

Key facts

Drug.verifiedrevid
470602469
Drug.image
terlipressin.png
Drug.image_class
skin-invert-image
Drug.tradename
Terlivaz
Drug.routes_of_administration
Intravenous
Drug.ATC_prefix
H01
Drug.ATC_suffix
BA04
Drug.legal_US
Rx-only
Drug.protein_bound
~30%
Drug.CAS_number
14636-12-5
Drug.PubChem
72081
Drug.DrugBank
DB02638
Drug.ChemSpiderID
65067
Drug.UNII
7Z5X49W53P
Drug.KEGG
D06672
Drug.IUPAC_name
1-{[(4R,7S,10S,13S,16S,19R)-19-{[({[(aminoacetyl)amino]acetyl}amino)acetyl]amino}-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}-L-prolyl-N-(2-amino-2-oxoethyl)-L-lysinamide
Drug.C
52
Drug.H
74

via Wikipedia infobox

Chemical data

Formula
C52H74N16O15S2
Molecular weight
1227.4 g/mol
IUPAC name
(2S)-1-[(4R,7S,10S,13S,16S,19R)-19-[[2-[[2-[(2-aminoacetyl)amino]acetyl]amino]acetyl]amino]-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[(2S)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]pyrrolidine-2-carboxamide
SMILES
C1C[C@H](N(C1)C(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)NC(=O)CNC(=O)CNC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N
InChIKey
BENFXAYNYRLAIU-QSVFAHTRSA-N
XLogP
-5.8
Polar surface area
563 Ų
H-bond donors
16
H-bond acceptors
19
Formal charge
0

via PubChem

Drug data · ChEMBL

Max clinical phase
Approved
Molecule type
Protein
First approval
2022
Admin. routes
parenteral
Indications
cirrhosis of liver, septic shock, hemorrhage, kidney failure

via ChEMBL · EBI

Research

1,380 papers

via PubMed

Wikidata facts

Subclass of
peptide
Mass
1226.496
Has use
medication
Show 6 more facts
chemical formula
C₅₂H₇₄N₁₆O₁₅S₂
canonical SMILES
C1CC(N(C1)C(=O)C2CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)NC(=O)CNC(=O)CNC(=O)CN)C(=O)NC(CCCCN)C(=O)NCC(=O)N
isomeric SMILES
C1C[C@H](N(C1)C(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)NC(=O)CNC(=O)CNC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N
defined daily dose
12
medical condition treated
hepatorenal syndrome
legal status (medicine)
boxed warning
Sources (7)

via Wikidata · CC0

~4 min read

Encyclopedic overview

5 sections
Contents
  • Medical uses
  • Contraindications
  • Society and culture
  • References
  • External links

{{Infobox drug | verifiedrevid = 470602469 | image = terlipressin.png | image_class = skin-invert-image | alt =

| tradename = Terlivaz | Drugs.com = | pregnancy_category = | routes_of_administration = Intravenous | ATC_prefix = H01 | ATC_suffix = BA04 | ATC_supplemental =

Excerpted from Wikipedia’s “terlipressin” article, available under the CC BY-SA 4.0 licence.

Connections

Categories